Correlation Between Entegris and CERo Therapeutics

Can any of the company-specific risk be diversified away by investing in both Entegris and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entegris and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entegris and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Entegris and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entegris with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entegris and CERo Therapeutics.

Diversification Opportunities for Entegris and CERo Therapeutics

-0.08

Correlation Coefficient

Entegris  CERo Therapeutics

Good diversification

The 3 months correlation between Entegris and CERo is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Entegris and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Entegris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entegris are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Entegris i.e., Entegris and CERo Therapeutics go up and down completely randomly.

Pair Corralation between Entegris and CERo Therapeutics

Given the investment horizon of 90 days Entegris is expected to under-perform the CERo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Entegris is 10.83 times less risky than CERo Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The CERo Therapeutics Holdings is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  2.01  in CERo Therapeutics Holdings on September 28, 2024 and sell it today you would lose (1.22) from holding CERo Therapeutics Holdings or give up 60.7% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	75.2%
Values	Daily Returns

Entegris  vs.  CERo Therapeutics Holdings

Entegris

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Entegris has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

CERo Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Entegris and CERo Therapeutics

The main advantage of trading using opposite Entegris and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entegris position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.

The idea behind Entegris and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.